SmartFuse: Game-changer to create a new gold-standard for spinal fusion surgery with wirelessly technology

Objective

Spinal surgery has a significant failure rate of 18% leading to devastating complications for patients. With the knowledge that bone remodels naturally using electric signals, we are transferring cutting edge neuromodulation technology into the orthopaedic field. We incorporate our proprietary, wirelessly powered bio-electrical stimulation system into standard orthopaedic implants. Our first product, SmartFuse, addresses the issues of non-union and bone overgrowth in spinal fusion surgery by harnessing the local delivery of electrical stimulation to accelerate bone growth and control the formation of new bone. In addition to accelerating and controlling bone growth, SmartFuse can measure the quantity and quality of new bone, enabling real-time feedback on the progress of healing to the physician and other caregivers. Through EIC funding, we will complete a clinical pilot trial, and prepare a pivotal study demonstrating efficiency and safety to achieve the necessary market approvals.

Fields of science

• medical and health sciences › clinical medicine › surgery
• medical and health sciences › clinical medicine › orthopaedics
• medical and health sciences › medical biotechnology › implants

Programme(s)

• HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
• HORIZON.3.1.2 - The Accelerator

Topic(s)

• HORIZON-EIC-2021-ACCELERATOROPEN-01 - EIC Accelerator Open 2021

Call for proposal

HORIZON-EIC-2021-ACCELERATOROPEN-01

See other projects for this call

Funding Scheme

HORIZON-AG - HORIZON Action Grant Budget-Based

Coordinator

Intelligent Implants Sweden AB

Net EU contribution

€ 2 500 000,00

Address

Pepparedsleden 1 C/o Astrazeneca Bvh
431 53 Mölndal
Sweden

Region

Södra Sverige › Västsverige › Västra Götalands län

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 1 384 875,00